[go: up one dir, main page]

FR2788777B1 - COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V. - Google Patents

COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V.

Info

Publication number
FR2788777B1
FR2788777B1 FR9900743A FR9900743A FR2788777B1 FR 2788777 B1 FR2788777 B1 FR 2788777B1 FR 9900743 A FR9900743 A FR 9900743A FR 9900743 A FR9900743 A FR 9900743A FR 2788777 B1 FR2788777 B1 FR 2788777B1
Authority
FR
France
Prior art keywords
skin
cosmetic
peptides
aging
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9900743A
Other languages
French (fr)
Other versions
FR2788777A1 (en
Inventor
Karl Lintner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR9900743A priority Critical patent/FR2788777B1/en
Priority to AU30517/00A priority patent/AU3051700A/en
Priority to PCT/FR2000/000031 priority patent/WO2000043417A1/en
Publication of FR2788777A1 publication Critical patent/FR2788777A1/en
Application granted granted Critical
Publication of FR2788777B1 publication Critical patent/FR2788777B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9900743A 1999-01-22 1999-01-22 COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V. Expired - Lifetime FR2788777B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9900743A FR2788777B1 (en) 1999-01-22 1999-01-22 COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V.
AU30517/00A AU3051700A (en) 1999-01-22 2000-01-06 Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation
PCT/FR2000/000031 WO2000043417A1 (en) 1999-01-22 2000-01-06 Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900743A FR2788777B1 (en) 1999-01-22 1999-01-22 COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V.

Publications (2)

Publication Number Publication Date
FR2788777A1 FR2788777A1 (en) 2000-07-28
FR2788777B1 true FR2788777B1 (en) 2003-01-17

Family

ID=9541160

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9900743A Expired - Lifetime FR2788777B1 (en) 1999-01-22 1999-01-22 COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V.

Country Status (3)

Country Link
AU (1) AU3051700A (en)
FR (1) FR2788777B1 (en)
WO (1) WO2000043417A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC200053A1 (en) * 2002-01-04 2002-07-29 A M Exsymol S Use of L-arginine derivatives as photoprotective agents and optimizing the melanin response in cosmetic compositions
FR2836042B1 (en) 2002-02-15 2004-04-02 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING POCKETS AND DARK CIRCLES UNDER EYES
WO2004043482A1 (en) * 2002-11-08 2004-05-27 Societe D'extraction Des Principes Actifs (Vincience) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
FR2846883B1 (en) * 2002-11-08 2004-12-24 Vincience COSMETIC COMPOSITION COMPRISING, AS ACTIVE INGREDIENT, AT LEAST ONE PEPTIDE AND USE OF THIS PEPTIDE
JP4256389B2 (en) 2003-11-17 2009-04-22 セダーマ Composition comprising a mixture of tetrapeptide and tripeptide
DE202004012807U1 (en) * 2004-08-13 2004-10-21 Henkel Kgaa Cosmetic and dermatological compositions with DNA repair enzymes and oligopeptides
KR101264441B1 (en) 2004-10-18 2013-05-14 바스프 뷰티 케어 솔루션즈 프랑스 에스에이에스 Oligopeptides and their use in cosmetics
FR2890310B1 (en) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli USE OF PROTOBERBERINS AS AGENTS REGULATING THE ACTIVITY OF THE PILOSEBACEE UNIT
EP1984387B1 (en) 2006-02-16 2017-05-31 Sederma Polypeptides kxk and their use
FR2900573B1 (en) 2006-05-05 2014-05-16 Sederma Sa NOVEL COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE CONTAINING AT LEAST ONE BLOCKED AROMATIC CYCLE
FR2904549B1 (en) 2006-08-03 2012-12-14 Sederma Sa COMPOSITION COMPRISING SARSASAPOGENIN
JP2008074788A (en) * 2006-09-22 2008-04-03 Rohto Pharmaceut Co Ltd Elastin production promoter
FR2918883B1 (en) 2007-07-17 2010-01-15 Oreal USE OF A CULTIVE BACTERIAL EXTRACT ON THERMAL WATER FOR THE TREATMENT OF DRY SKINS
PL2205623T3 (en) * 2007-10-29 2016-09-30 Protective skin care tetrapeptides
PL2065029T3 (en) 2007-11-30 2013-09-30 Evonik Degussa Gmbh Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
FR2939799B1 (en) 2008-12-11 2011-03-11 Sederma Sa COSMETIC COMPOSITION COMPRISING ACETYL OLIGOGLUCURONANS.
FR2941232B1 (en) 2009-01-16 2014-08-08 Sederma Sa NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES
FR2941231B1 (en) 2009-01-16 2016-04-01 Sederma Sa NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMO-PHARMACEUTICAL USES
WO2010082177A2 (en) 2009-01-16 2010-07-22 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2944435B1 (en) 2009-04-17 2011-05-27 Sederma Sa COSMETIC COMPOSITION COMPRISING ORIDONIN
KR101746238B1 (en) 2009-04-22 2017-06-12 디에스엠 아이피 어셋츠 비.브이. Peptide compositions
FR2945939B1 (en) 2009-05-26 2011-07-15 Sederma Sa COSMETIC USE OF TYR-ARG DIPEPTIDE TO FIGHT SKIN RELEASE.
FR2955326B1 (en) 2010-01-18 2015-01-02 Sederma Sa NOVEL LIPO-PHOSPHATE OR LIPO-SULFATE COMPOUND, COMPOSITIONS CONTAINING SAME AND COSMETIC AND DERMOPHARMACEUTICAL USES
FR2958541B1 (en) 2010-04-08 2012-05-18 Sederma Sa COSMETIC USE OF GERANYLGERANYL-2-PROPANOL
FR2958641B1 (en) 2010-04-08 2014-12-26 Sederma Sa NOVEL POLYTERPENIC COMPOUNDS, COSMETIC, NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES THEREOF.
FR2970868B1 (en) 2011-01-31 2023-10-27 Sederma Sa EXTRACT OF PLANT ORIGIN, COMPOSITION CONTAINING IT, METHOD OF OBTAINING BY PLANT CULTURE AND USES IN THE COSMETIC, PHARMACEUTICAL AND COSMECEUTICAL FIELDS
EP2673288B1 (en) 2011-02-09 2016-10-05 Organo Balance GmbH Peptide for use in the treatment of skin conditions
EP2704728A4 (en) * 2011-05-03 2015-04-22 Dermachip Inc Expression signatures of genes and gene networks associated with skin aging
SG187271A1 (en) * 2011-07-07 2013-02-28 Agency Science Tech & Res Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic
FR2978351B1 (en) 2011-07-28 2014-02-21 Sederma Sa PLANT ORIGINAL MATERIAL, COMPOSITION CONTAINING SAME, AND TOPICAL COSMETIC USE
FR2997299B1 (en) 2012-10-30 2014-12-26 Sederma Sa ASSOCIATION OF PLANT EXTRACTS, COSMETIC ACTIVE INGREDIENT AND COMPOSITION CONTAINING THE SAME, AND COSMETIC TOPICAL USE
FR2998570B1 (en) * 2012-11-26 2016-12-02 Sederma Sa PEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND PARTICULARLY COSMETIC USES THEREOF
ITRM20130199A1 (en) 2013-04-03 2014-10-04 Irbm Science Park S P A PEPTIDES FOR DERMATOLOGICAL AND / OR COSMETIC USE
WO2014167464A1 (en) 2013-04-08 2014-10-16 Sederma Production method of meristematic cells of plantago lanceolata, composition comprising said cells or their cellular extract, and cosmetic, nutraceutical and dermatological uses
FR3107708B1 (en) 2020-02-28 2025-03-07 Alganelle Recombinant microalgae capable of producing KTTKS peptides, polypeptides and proteins and their derivatives, and their associated methods and uses
US20230320967A1 (en) * 2020-09-11 2023-10-12 Chemyunion Ltda. Composition, use of the composition, cosmetic method for modulating the production of sebum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07324097A (en) * 1994-05-30 1995-12-12 Daicel Chem Ind Ltd Interleukin 6 antagonist, peptides or pharmaceutically permissible salts thereof
JPH08311098A (en) * 1995-05-22 1996-11-26 Daicel Chem Ind Ltd New peptides and interleukin 6 antagonistic agent containing the peptide

Also Published As

Publication number Publication date
AU3051700A (en) 2000-08-07
FR2788777A1 (en) 2000-07-28
WO2000043417A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
FR2788777B1 (en) COSMETIC OR DERMOPHARMACEUTICAL USE OF PEPTIDES FOR THE REGULATION OF SKIN IMMUNOLOGICAL MALFUNCTIONS AND IN SKIN INFLAMMATION INDUCED BY AGING OR BY U.V.
NO975953L (en) Recombinant adenoviruses, their use in the preparation of AAVs, complementary cell line, and pharmaceutical preparations containing the adenoviruses
HK1096974A1 (en) Antibody against human parathormone related peptides
FR2738746B1 (en) USE OF AT LEAST ONE PEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICAMENT
DE69528131D1 (en) Cosmetic preparations
EP0793501A4 (en) 'IN VIVO' ACTIVATION OF TUMOR-SPECIFIC-CYTOTOXIC T-CELLS
FR2674748B1 (en) USE OF SPHINGOLIPIDS IN THE PREPARATION OF A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION PROTECTING THE SKIN AND HAIR FROM THE HARMFUL EFFECTS OF ATMOSPHERIC POLLUTION.
BR9505368A (en) Cosmetic or dermatogogic composition water-in-oil
FR2698003B1 (en) COSMETIC COMPOUND, COSMETIC COMPOSITION COMPRISING THE SAME, AND USE OF THIS COMPOUND TO PRESERVE MOISTURE OF THE SKIN AND HAIR.
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
DE59805545D1 (en) AQUEOUS COSMETIC PREPARATIONS IN STICK FORM
FR2704753B1 (en) USE OF DERIVATIVES OF 4-THIO RESORCIN OR 4-THIO 1-3-DIHYDROXYBENZENE, IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS WITH DEPIGMENTING ACTION.
ATE217867T1 (en) N-(PYRIMIDINYL)-BENZENESULFONAMIDE AS MEDICINAL PRODUCTS
FR2765106B1 (en) USE OF CROSSLINKED TANNINS IN THE PRESENCE OF NON-CROSSLINKED PROTEINS WITH TANNINS AS COSMETIC AGENTS TO IMPROVE SKIN SMOOTHING AND / OR TO OBTAIN AN ASTRINGENT EFFECT
FR2766366B1 (en) USE OF AT LEAST ONE LIPOAMINOACID AS AN ANTAGONIST OF THE SUBSTANCE P IN A COSMETIC FORMULATION FOR SOOTHING AND / OR PROTECTING ALL SKIN TYPES AND, IN PARTICULAR, SENSITIVE SKIN
FR2765803B1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
DE69629027D1 (en) COSMETIC PREPARATION FOR PREVENTING AND ELIMINATING SKIN DAMAGE
FR2713483B1 (en) Cosmetic composition opposing the aging of the skin.
FR2837384B1 (en) USE OF A VANILLA EXTRACT FOR THE PROTECTION OF THE SKIN AND ITS INCORPORATION IN COSMETIC AND / OR DERMATOLOGICAL PREPARATIONS
FR2718640B1 (en) Cosmetic and / or dermatological composition, in particular for depigmenting the skin, its uses.
FR2759910B1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR STRENGTHENING THE BUST, STIMULATING THE HAIR SYSTEM AND INHIBITION OR HAIRY SYSTEM, CONTAINING KIGELIA AFRICANA EXTRACTS
FR2697750B1 (en) Cosmetic preparations revitalizing the skin.
FR2751217B1 (en) USE OF IODO-3 PROPYNYL-2 BUTYLCARBAMATE IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA
DE59506998D1 (en) COSMETIC AGENTS
GB9700322D0 (en) Shampoo and conditioner for hair and/or for the body

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20